tiprankstipranks
CNBX Pharmaceuticals (CNBX)
OTHER OTC:CNBX
Holding CNBX?
Track your performance easily

CNBX Pharmaceuticals (CNBX) Technical Analysis

120 Followers

Summary of all the Indicators

Overall Consensus
Sell
3Bullish
6Neutral
10Bearish
Technical Analysis Consensus
Sell
1Bullish
6Neutral
2Bearish
Moving Average Consensus
Strong Sell
2Bullish
0Neutral
8Bearish
CNBX Pharmaceuticals’s (CNBX) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting CNBX Pharmaceuticals is a Sell.
CNBX Pharmaceuticals’s (CNBX) 20-Day exponential moving average is 0.01, while CNBX Pharmaceuticals’s (CNBX) share price is <$0.1, making it a Sell.
CNBX Pharmaceuticals’s (CNBX) 50-Day exponential moving average is 0.01, while CNBX Pharmaceuticals’s (CNBX) share price is <$0.1, making it a Sell.

CNBX Pharmaceuticals (CNBX) Pivot Points

Nov 22, 2024, 07:31 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
<0.01
<0.01
<0.01
0.01
0.01
0.01
0.02
Fibonacci
<0.01
<0.01
<0.01
0.01
0.01
0.01
0.01
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

CNBX Pharmaceuticals (CNBX) Moving Averages

Nov 22, 2024, 07:31 AM
Period
Simple
Exponential
MA5
<0.01Buy
0.01Sell
MA10
<0.01Buy
0.01Sell
MA20
0.01Sell
0.01Sell
MA50
0.01Sell
0.01Sell
MA100
0.01Sell
0.01Sell
CNBX Pharmaceuticals’s (CNBX) 10-Day exponential moving average is 0.01, while CNBX Pharmaceuticals’s (CNBX) share price is <$0.1, making it a Sell.
CNBX Pharmaceuticals’s (CNBX) 100-Day exponential moving average is 0.01, while CNBX Pharmaceuticals’s (CNBX) share price is <$0.1, making it a Sell.
CNBX Pharmaceuticals’s (CNBX) stock price is <$0.1 and CNBX Pharmaceuticals’s (CNBX) 50-day simple moving average is 0.01, creating a Sell signal.
CNBX Pharmaceuticals’s (CNBX) stock price is <$0.1 and CNBX Pharmaceuticals’s (CNBX) 100-day simple moving average is 0.01, creating a Sell signal.

CNBX Pharmaceuticals (CNBX) Technical Indicators

Nov 22, 2024, 07:31 AM
Name
Value
Implied Action
RSI (14)
45.96
Neutral
STOCH (9,6)
30.77
Neutral
STOCHRSI (14)
30.77
Neutral
MACD (12,26)
>-0.01
Sell
ADX (14)
23.44
Neutral
Williams %R
-69.23
Buy
CCI (14)
-14.32
Neutral
ATR (14)
<0.01
-
Ultimate Oscillator
41.73
Neutral
ROC
0.00
-
CNBX Pharmaceuticals’s (CNBX) Relative Strength Index (RSI) is 45.96, creating a Neutral signal.
CNBX Pharmaceuticals’s (CNBX) Trend Strength Indicator (ADX) is 23.44, creating a Neutral signal.
CNBX Pharmaceuticals’s (CNBX) Commodity Channel Index (CCI) is -14.32, creating a Neutral signal.

FAQ

Is CNBX a Buy, Hold, or Sell?
Based on CNBX’s technical indicators, CNBX is a Sell.
    What is CNBX’s RSI (14)?
    CNBX’s RSI (14) is 45.96, which suggests CNBX is a Neutral.
      What is CNBX’s MACD?
      CNBX’s MACD is >-0.01, which suggests CNBX is a Sell.
        What is CNBX’s 5-day moving average?
        CNBX’s 5-day moving average is <0.01, which suggests CNBX is a Buy.
          What is CNBX’s 20-day moving average?
          CNBX 20-day moving average is 0.01, which suggests CNBX is a Sell.
            What is CNBX’s 50-day moving average?
            CNBX’s 50-day moving average is 0.01, which suggests CNBX is a Sell.
              What is CNBX’s 200-day moving average?
              Currently, no data Available
              What is CNBX’s Williams % R (14)?
              CNBX’s Williams % R (14) is -69.23, which suggests CNBX is a Buy.
                What is CNBX’s CCI (14)?
                CNBX’s CCI (14) is -14.32, which suggests CNBX is a Neutral.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis